U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX19713156: GSM7103657: WT A549, MOCK, 2dpi,2; Homo sapiens; RNA-Seq
1 ILLUMINA (Illumina NovaSeq 6000) run: 16.7M spots, 1.7G bases, 626.5Mb downloads

External Id: GSM7103657_r1
Submitted by: Lim & tenOever labs, Microbiology, Icahn School of Medicine at Mount Sinai
Study: ADAR1 biology can hinder effective antiviral RNA interference
show Abstracthide Abstract
Viruses constantly evolve and adapt to the antiviral defenses of their hosts. The biology of viral circumvention of these selective pressures can often be attributed to the acquisition of novel antagonistic gene products or by rapid genome change that prevents host recognition. To study viral evasion of RNA interference (RNAi)-based defenses, we established a robust antiviral system in mammalian cells using recombinant Sendai virus designed to be targeted by endogenous host microRNAs (miRNAs) with perfect complementarity. Using this system, we previously demonstrated the intrinsic ability of positive-strand RNA viruses to escape this selective pressure via homologous recombination, which was not observed in negative-strand RNA viruses. Here we show that given extensive time, escape of miRNA-targeted Sendai virus was enabled by host adenosine deaminase acting on RNA 1 (ADAR1). Independent of the viral transcript targeted, ADAR1 editing resulted in disruption of the miRNA-silencing motif, suggesting an intolerance for extensive RNA:RNA interactions necessary for antiviral RNAi. This was further supported in N. benthamiana, where exogenous expression of ADAR1 interfered with endogenous RNAi. Together, these results suggest that ADAR1 diminishes the effectiveness of RNAi and may explain why it is absent in species that utilize this antiviral defense system. Overall design: RNA-sequencing of mammalian cells lines infected with recombinant Sendai viruses that have sequences with perfectly complemenatrity to host miRNAs added into the 3' UTR of the N gene or P gene to produce an artificial miRNA-based antiviral RNAi. Cell lines, which include A549s, STAT1 KO A549s, STAT1/ADAR1 Double KO A549s, MEFs, and MDCKs were infected and RNA was collected at various timepoints post infection to assess host response and changes to viral genome. Samples where differential gene expression in host cells is assessed are in triplicate.
Sample: WT A549, MOCK, 2dpi,2
SAMN33799950 • SRS17081542 • All experiments • All runs
Organism: Homo sapiens
Library:
Name: GSM7103657
Instrument: Illumina NovaSeq 6000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: Trizol phenol chloroform or Qiagen Rneasy kit Poly-A enrichment and TruSeq stranded OR TruSeq stranded Total RNA with RiboZero Gold
Runs: 1 run, 16.7M spots, 1.7G bases, 626.5Mb
Run# of Spots# of BasesSizePublished
SRR2390142516,721,2661.7G626.5Mb2023-03-21

ID:
27020772

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...